Strengthening Aqsens Health’s board with diagnostics market expertise
We're pleased to welcome Paul Eros to our Board of Directors and announce Pekka Hänninen as our new Chairman. We're deeply grateful to Aaron Michelin for his contributions and look forward to continued collaboration.
Vilhelmiina Juusti Appointed as a COO of Aqsens Health Oy Ltd.
Aqsens Health Oy Ltd., a leading provider of biosensor based analysis, is pleased to announce the appointment of Vilhelmiina Juusti as its new Chief Operating Officer (COO).
Aqsens Health and Tartu University teaming up to research the capabilities of different phages as biosensors in diagnostics
Aqsens Health is pleased to announce its collaboration with Professor Tambet Teesalu's esteemed research group at the Laboratory of Precision and Nanomedicine, University of Tartu in Estonia. Together, they will delve into extensive research to explore the capabilities of different phages as biosensors.
Aqsens Health’s board of directors strengthened with medtech industry expertise – An interview with Tuomo Pätsi
Aqsens Health is happy to announce that Mr. Tuomo Pätsi has been elected to Aqsens Health’s board of directors at Aqsens Health’s annual general meeting. Mr. Pätsi has over 30 years of experience in the medical industry, and he has led several biotech companies through successful market-entry and commercialization…
Aqsens Health and Equity Health Insurance sign a Memorandum of Understanding to deepen their collaboration in Ghana
Aqsens Health (Finland) and Equity Health Insurance (Ghana) signed a Memorandum of Understanding to accelerate market entry for AQ Malaria and other future tests for developing economies…
Aqsens Health and NMIMR on the path towards the commercialization of AQ Malaria
Aqsens Health received a meaningful contribution to its research and validation project in Ghana from the Finnpartnership business partnership program funded by the Ministry for Foreign Affairs of Finland.
Aqsens Health sharpens its focus around urinary tract diseases and starts looking into possibilities in the well-being sector.
Aqsens Health has decided to concentrate the company’s research on urine-based analysis, venturing further into the diagnostics of urologic and urinary tract conditions and well-being applications.
Aqsens’ first E-TRF certification program successfully completed
Aqsens Health’s Ghana training team successfully completed AQH’s first E-TRF and biosensor training and certification program in Turku at the end of March. This is a major milestone for the company that’s expanding its international operations and preparing for a scale-up.
